The COVID-19 pandemic has disrupted the provision of genetic care in Canada. As genetic services are asked to gradually resume, a roadmap is needed to ensure that clinical care decisions for at-risk patients are transparent and equitable, that postponed care is resumed and that patients with or waiting for a genetic diagnosis are not disproportionately affected or abandoned. The purpose of this document is to highlight the guiding ethical principles and stakeholder considerations in resuming genetic services. Considerations highlighted are: 1) environment of practice; 2) nature of consult; 3) patient factors; 4) provider factors; and 5) laboratory factors. (Dr. Elaine Suk-Ying Goh, https://jmg.bmj.com/content/early/2020/11/15/jmedgenet-2020-107394 )